Jian Liu
- Cancer Research top 1%
- MicroRNA in disease regulation 23
- Cancer-related molecular mechanisms research 23
- Immunology top 2%
- Immune cells in cancer 16
- Molecular Biology top 2%
- RNA modifications and cancer 20
- Glycosylation and Glycoproteins Research 17
- Oncology top 2%
- Peptidase Inhibition and Analysis 17
- Cancer Immunotherapy and Biomarkers 15
- Cancer Cells and Metastasis 15
Jian Liu
287 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Cancer Research 1.5k
- Immunology 1.4k
- Molecular Biology 3.4k
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 946
Countries citing papers authored by Jian Liu
This map shows the geographic impact of Jian Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Liu more than expected).
Fields of papers citing papers by Jian Liu
This network shows the impact of papers produced by Jian Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Liu. The network helps show where Jian Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jian Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 21 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 43 | |
| 5 | 2022 | 8 | |
| 6 | 2021 | 22 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 21 | |
| 9 | 2020 | 13 | |
| 10 | 2020 | 31 | |
| 11 | 2019 | 2 | |
| 12 | 2018 | 0 | |
| 13 | 2017 | 62 | |
| 14 | 2017 | 0 | |
| 15 | 2015 | 2 | |
| 16 | 2013 | 1 | |
| 17 | [Cloning, expression and function analysis of thioredoxin-1 protein of Schistosoma japonicum]. | 2012 | 3 |
| 18 | Effects of Tetramethylpyrazine on Expression of Early Apoptosis and Caspase-3 Gene in Rats With Spinal Cord Injury | 2011 | 1 |
| 19 | 2010 | 1 | |
| 20 | The research progress about internal mammary lymph node metastasis in breast cancer by using imaging technologies | 2010 | 1 |
About Jian Liu
Jian Liu is a scholar working on Cancer Research, Oncology and Immunology, having authored 307 papers that have together received 6.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (23 papers), RNA modifications and cancer (20 papers), Glycosylation and Glycoproteins Research (17 papers), Peptidase Inhibition and Analysis (17 papers), Immune cells in cancer (16 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Cancer Cells and Metastasis (15 papers). The work is most often cited by research in Cancer Research (1.5k citations), Immunology (1.4k citations) and Molecular Biology (3.4k citations). Jian Liu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Guo‐Ping Shi, Peter Libby, Jiusong Sun, Galina K. Sukhova, Tao Wen, Paul J. Wolters, Gökhan S. Hotamışlıgil, Cem Z. Görgün, Jonathan N. Glickman and Jie Zhang. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.